CMS to end subsidies for Medicare drug plan premiums
Emily Olsen / healthcaredive - The CMS said the program, which went into effect last year to stabilize Part D premiums and enrollment, isn’t needed anymore. One researcher said some enrollees could see higher premium increases in 2027 as a result.
AI Summary: CMS will terminate its Part D premium stabilization subsidy, a program that helped blunt year-to-year premium swings for Medicare drug plans. The move removes a federal backstop aimed at keeping beneficiaries’ premiums lower, likely pushing costs onto enrollees and plan sponsors while igniting concerns about affordability for seniors and people on fixed incomes.
Related Stories
Thousands of Medicare beneficiaries unexpectedly lose 'free' drug plans / 18 days
Bill would let patient drug spending count toward insurance deductibles / 3 months
Optum Rx/Caremark and FTC edge toward settlement in insulin case / 4 months
Tampa General sues Eli Lilly over pulled 340B discounts / 18 days
340B discounts face reform as profits outpace patient benefit / 3 months
AbbVie sues HHS over 340B patient definition and guidance / 3 months
D.C. appeals court upholds HHS control in 340B rebate dispute / 4 days
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Health IT, Genetics, Biotech, Medicaid and look for the RSS link.
StackHealth Time Machine